Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics granted inducement equity awards to four new employees covering an aggregate of 48,800 shares. The grants consist of options to purchase 18,000 shares and RSUs covering 30,800 shares, subject to standard four-year vesting terms.
Key figures
- Rsus granted
- 30800
- Exercise price
- 43.51
- Options granted
- 18000
- Total inducement shares
- 48800
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.